Treatments offered through these projects include electroconvulsive therapy (ECT), magnetic seizure therapy (MST) and repetitive transcranial magnetic stimulation (rTMS).
Those interested in participating in a clinical trial receive a psychiatric consultation and meet with a research analyst, who will conduct a more detailed screening to ensure eligibility.
Who can be referred?
For ECT: Severe and/or treatment-resistant psychiatric illnesses - unipolar depression, bipolar disorder, schizoaffective disorder and schizophrenia.
For rTMS: Depression that has not responded to at least one antidepressant trial, and bipolar depression.
For MST: Unipolar depression, bipolar disorder, schizoaffective disorder and schizophrenia.
For tDCS (transcranial director current stimulation): Older adults with mild cognitive impairment and/or late-onset depression.
Note: People with active substance use disorders may not be appropriate for a brain stimulation treatment for safety reasons, but they can still be referred for consultation.
Please have your doctor complete a CAMH referral form and fax it to Access CAMH, CAMH’s centralized intake at 416 979-6815.
If you have any questions about the referral or intake process, please call Access CAMH.